Search Results for "Mitomycin C With Hipec For Appendeceal"
Original Source: Impact of the hyperthermic intraperitoneal chemotherapy on the fluid-electrolytes changes and on the acid-base balance.
BACKGROUND: Hyperthermic intraperitoneal chemoperfusion (HIPEC) is an innovative treatment of the peritoneal carcinomatosis with potential iatrogenicity. This observational study was designed to improve our understanding of HIPEC's impact on the renal and respiratory functions, on temperature, blood cells counts, body fluids/electrolytes and acid-base balance. METHODS: We retrospectively analyzed the perioperative care of 20 patients that underwent HIPEC with oxaliplatin (n=19) and mitomycin C (n=1). The ab...
Matching Channels
None
Matching News
Mitomycin and hemocyanin of differing benefit in bladder cancer
NEW YORK (Reuters Health) - After resection of non-muscle-invasive bladder cancer (NMIBC) without carcinoma in situ, mitomycin more effectively prevents recurrence but keyhole limpet hemocyanin (K...
The results of our trial—the largest in anal cancer to date—show that fluorouracil and mitomycin with 50·4 Gy radiotherapy in 28 daily fractions should remain standard practice in the UK.
Radiation plus fluorouracil/mitomycin should remain standard of care for anal carcinoma
NEW YORK (Reuters Health) - Patients with anal carcinoma do better if they receive radiation concurrently with fluorouracil plus mitomycin (FU/MMC) than with fluorouracil/cisplatin (FU/CDDP), a ne...
Mobius brand Mitosol (mitomycin for solution) Kit for Ophthalmic Use: Recall-May Not be Sterile
Audience: Ophthalmology ISSUE: Mobius Therapeutics announced that it is conducting a voluntary recall of 2 lots of Mitosol (mitomycin for solution), 0.2 mg/vial, Kit for Ophthalmic Use. The company c...
Bladder cancer remission improved by adding electromotive mitomycin to BCG
In patients with stage pT1 urothelial bladder cancer, intravesical bacillus Calmette-Gu?rin (TheraCys, TICE BCG) combined with electromotive mitomycin-C produces higher remission rates and longer...
On 10 January 2013, Mobius Therapeutics, LLC, St. Louis, MO, announced today that it is conducting a voluntary recall of 2 lots of Mitosol® (mitomycin for solution), 0.2 mg/vial, Kit for Ophthalmic U...
Comment on ‘Deep sclerectomy with mitomycin C in eyes with failed glaucoma surgery and pseudophakia’
Comment on ‘Deep sclerectomy with mitomycin C in eyes with failed glaucoma surgery and pseudophakia’ Eye advance online publication, December 7 2012. doi:10.1038/eye.2012.245 Au...
Polypropylene vs silicone Ahmed valve with adjunctive mitomycin C in paediatric age group: a prospective controlled study Eye advance online publication, April 12 2013. doi:10.1038/eye.2013....
Matching PubMed Articles
BACKGROUND:: The combination of cytoreductive surgery (CS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is the treatment of choice for selected patients with peritoneal carcinomatosis (PC) of...
BACKGROUND: Perioperative intraperitoneal chemotherapy is used as an adjunct to cytoreductive surgery (CS) for peritoneal carcinomatosis (PC) in order to prolong survival. Worldwide, hyperthermic intr...
Background: Cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) can improve the prognosis of selected patients with peritoneal surface malignancy (PSM). Usually,...
OBJECTIVES: To analyze the outcomes of cytoreductive surgery and HIPEC in patients with peritoneal carcinomatosis from ovarian cancer. METHODS: Fifty-three patients with peritoneal carcinomatosis from...
BACKGROUND: Hyperthermic intraperitoneal chemoperfusion (HIPEC) is an innovative treatment of the peritoneal carcinomatosis with potential iatrogenicity. This observational study was designed to impro...
